By Patrick Thomas

Altaire Pharmaceuticals Inc. said Wednesday that it is voluntarily recalling some of its eye drop products sold at CVS Health Corp. (CVS).

The company said the recall of certain over-the-counter drops, ointments and solutions meant for the eyes is a precautionary measure due to management concerns regarding the sufficiency of quality assurance controls over critical systems in the factory.

The Food and Drug Administration has determined these issues indicate a lack of sterility assurance, the company said.

Write to Patrick Thomas at patrick.thomas@wsj.com

(END) Dow Jones Newswires

July 10, 2019 20:21 ET (00:21 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more CVS Health Charts.